Showing results (221-230 of 682) with videos related to

Sort By:
Pageof 69
Arthritis and Rheumatism|November 6, 2004
Prolonged bleeding time and lupus anticoagulant: a second paradox in the antiphospholipid syndromeR T Urbanus, H B de Laat, P G de Groot, et al.
The Journal of Clinical Investigation|September 1, 1994
Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing bloodH F Heynen, M Lozano Molero, P G de Groot, et al.
Current Opinion in Hematology|April 7, 2007
Fibrinolysis and the risk of venous and arterial thrombosisMirjam E Meltzer, Carine J M Doggen, Philip G de Groot, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2013
Factor VIII concentrate infusion in patients with haemophilia results in decreased von Willebrand factor and ADAMTS-13 activityE R van Bladel, A Tuinenburg, M Roest, et al.
Hypertension (Dallas, Tex. : 1979)|February 1, 1997
Cyclosporin A increases nitric oxide activity in vivoE S Stroes, T F Lüscher, F G de Groot, et al.
British Journal of Haematology|January 28, 2009
Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young menMirjam E Meltzer, Carine J M Doggen, Philip G de Groot, et al.
Clinical and Experimental Hypertension|January 1, 1981
Development of hypertension in spontaneously hypertensive rats after gonadectomy: effects of secobarbital anesthesia on the blood pressureR G ten Berg, F P Nijkamp, W de Jong, et al.
Thrombosis and Haemostasis|May 4, 1992
Lupus anticoagulant activity is frequently dependent on the presence of beta 2-glycoprotein IJ D Oosting, R H Derksen, H T Entjes, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 26, 1999
Determination of coagulation factor VIII activity by a chromogenic substrate method on STA, an automated coagulation analyzerH A Kleinveld, N E Andersson, H van Voorthuizen, et al.
Pageof 69